SCHEMBL23823345

SCHEMBL23823345

CSCn1cccn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8176701 0.98
SCHEMBL3080297 0.80 FDPS (0.45)
SCHEMBL3080934 0.80 FDPS (0.45)
SCHEMBL18191068 0.77
SCHEMBL20083635 0.76
SCHEMBL10680 0.74
SCHEMBL647572 0.72
Water SCHEMBL3086211 0.72 TSHR (0.44)
Bromide SCHEMBL714157 0.72
Hydrochloric Acid SCHEMBL31520468 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230054781-A1 METHODS AND COMPOSITIONS FOR MODULATING SPLICING SKYHAWK THERAPEUTICS, INC. 2023-02-23 US disclosed
WO-2021180235-A1 INHIBITOR OF ENHANCER OF ZESTE HOMOLOGUE 2, AND USE THEREOF 四川海思科制药有限公司 2021-09-16 WO disclosed